Published in PLoS One on November 16, 2015
Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis. J Clin Invest (2017) 0.75
Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun (1997) 7.87
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol (2002) 5.52
LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol (2010) 3.91
Vagaries of conditional gene targeting. Nat Immunol (2007) 3.51
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell (2009) 3.36
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol (2006) 3.24
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A (2002) 3.01
Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem (2006) 2.79
Rapid generation of inducible mouse mutants. Nucleic Acids Res (2003) 2.77
Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J Immunol (2009) 2.44
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest (2004) 2.30
Two pathways for lysophosphatidic acid production. Biochim Biophys Acta (2008) 2.20
Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics (2007) 2.15
Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat Struct Mol Biol (2011) 1.87
Structural basis of substrate discrimination and integrin binding by autotaxin. Nat Struct Mol Biol (2011) 1.81
Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis. J Exp Med (2012) 1.76
Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res (2009) 1.54
Autotaxin--an LPA producing enzyme with diverse functions. J Biochem (2010) 1.49
Molecular mechanisms of lysophosphatidic acid action. Prog Lipid Res (2003) 1.46
A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. J Pharmacol Exp Ther (2010) 1.42
Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie (2010) 1.32
ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol (2010) 1.18
Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med (2013) 1.15
Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta (2012) 1.14
Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.13
Chemical evolution of autotaxin inhibitors. Chem Rev (2012) 1.12
Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J Lipid Res (2011) 1.11
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. J Exp Med (2012) 1.07
Current progress in non-Edg family LPA receptor research. Biochim Biophys Acta (2012) 1.07
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta (2012) 1.04
Autotaxin inhibitors: a patent review. Expert Opin Ther Pat (2013) 1.03
Autotaxin: structure-function and signaling. J Lipid Res (2014) 1.00
Conditionals by inversion provide a universal method for the generation of conditional alleles. Proc Natl Acad Sci U S A (2013) 0.95
Autotaxin and lysophospholipids in rheumatoid arthritis. Curr Opin Investig Drugs (2010) 0.94
Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice. FASEB J (2014) 0.92
A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension. PLoS One (2014) 0.90
Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions. FEBS Lett (2014) 0.88
Autotaxin emerges as a therapeutic target for idiopathic pulmonary fibrosis: limiting fibrosis by limiting lysophosphatidic acid synthesis. Am J Respir Cell Mol Biol (2012) 0.87
Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood (2014) 0.87
Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment. FASEB J (2014) 0.85
A metabolically-stabilized phosphonate analog of lysophosphatidic acid attenuates collagen-induced arthritis. PLoS One (2013) 0.84
Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis. Mol Cancer Res (2014) 0.84
Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice. Genet Mol Res (2004) 0.83
Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer. Prog Lipid Res (2015) 0.82
Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions. Biochim Biophys Acta (2012) 0.80
Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression. FASEB J (2015) 0.79
[Lysophosphatidic acid: a "bioactive" phospholipid]. Med Sci (Paris) (2004) 0.76
Hepatocyte Autotaxin expression promotes liver fibrosis and cancer. Hepatology (2016) 0.81